Similar medications and substitutes for LANADELUMAB-FLYO
In short: Takhzyro (LANADELUMAB-FLYO) belongs to the Plasma Kallikrein Inhibitor class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Takhzyro is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Takhzyro in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.